Press Releases

View Archive: 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003

12.15.08
FibroGen Has Commenced an Open-Label, Phase 1 Clinical Trial of FG-3019, Anti-Connective Tissue Growth Factor (CTGF) Investigational Therapy, in Patients with Pancreatic Cancer

12.4.08
FibroGen Appoints K. Peony Yu, M.D., Vice President, Clinical Development

12.1.08
FibroGen Appoints Frank H. Valone, M.D., Chief Medical Officer

11.10.08
FibroGen Announces New Research on HIF-PHI and Anti-CTGF Development Programs in Chronic Kidney Disease

8.29.08
Press Release Toshinari Tamura, Ph.D., Joins Board of Directors of FibroGen, Inc.

1.22.08
FibroGen Reports New Research on Development of HIF Prolyl Hydroxylase Inhibitors Related to Endothelial Progenitor Cells, Anti-Inflammation, Cytoprotection and Erythropoiesis